Ming Ho1, Yin-Yi Chang1, Wei-Chun Chang1, Hung-Chih Lin2, Mei-Hung Wang1, Wu-Chou Lin1, Tsan-Hung Chiu3. 1. Department of Obstetrics and Gynecology, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan. 2. Department of Pediatrics, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan. 3. Department of Obstetrics and Gynecology, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan. Electronic address: d4798@mail.cmuh.org.tw.
Abstract
OBJECTIVE: This study is to examine the effect of Lactobacillus rhamnosus GR-1 and Lactobacillusreuteri RC-14 taken orally before bedtime on Group B Streptococcus (GBS)-positive pregnant women with respect to becoming GBS negative. MATERIALS AND METHODS: In total, 110 pregnant women at 35-37 weeks of gestation who were diagnosed by GBS culture as being GBS positive for both vaginal and rectal GBS colonization were randomly assigned to be orally treated with two placebo capsules or two probiotic capsules (containing L. rhamnosusGR-1 and L. reuteriRC-14) before bedtime until delivery. All women were tested for vaginal and rectal GBS colonization again by GBS culture on admission for delivery. RESULTS: Of the 110 participants, 99 completed the study (49 in the probiotic group and 50 in the placebo group). The GBS colonization results changed from positive to negative in 21 women in the probiotic group (42.9%) and in nine women in the placebo group (18.0%) during this period (Chi-square p=0.007). CONCLUSION:Oral probiotic containing L. rhamnosusGR-1 and L. reuteriRC-14 could reduce the vaginal and rectal GBS colonization rate in pregnant women.
RCT Entities:
OBJECTIVE: This study is to examine the effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteriRC-14 taken orally before bedtime on Group B Streptococcus (GBS)-positive pregnant women with respect to becoming GBS negative. MATERIALS AND METHODS: In total, 110 pregnant women at 35-37 weeks of gestation who were diagnosed by GBS culture as being GBS positive for both vaginal and rectal GBS colonization were randomly assigned to be orally treated with two placebo capsules or two probiotic capsules (containing L. rhamnosus GR-1 and L. reuteri RC-14) before bedtime until delivery. All women were tested for vaginal and rectal GBS colonization again by GBS culture on admission for delivery. RESULTS: Of the 110 participants, 99 completed the study (49 in the probiotic group and 50 in the placebo group). The GBS colonization results changed from positive to negative in 21 women in the probiotic group (42.9%) and in nine women in the placebo group (18.0%) during this period (Chi-square p=0.007). CONCLUSION: Oral probiotic containing L. rhamnosus GR-1 and L. reuteri RC-14 could reduce the vaginal and rectal GBS colonization rate in pregnant women.
Authors: Kyle B Klopper; Elanna Bester; Shelly M Deane; Gideon M Wolfaardt; Leon M T Dicks Journal: Probiotics Antimicrob Proteins Date: 2019-06 Impact factor: 4.609
Authors: Geoffrey H Rosen; Tara M Randis; Purnahamsi V Desai; Katherine J Sapra; Bing Ma; Pawel Gajer; Michael S Humphrys; Jacques Ravel; Shari E Gelber; Adam J Ratner Journal: J Infect Dis Date: 2017-09-15 Impact factor: 5.226
Authors: Rachel E Hudson; Kathleen M Job; Casey L Sayre; Lubov V Krepkova; Catherine M Sherwin; Elena Y Enioutina Journal: Front Pharmacol Date: 2022-04-27 Impact factor: 5.988